This is a past event. Registration is closed. View other EU-ASEAN Business Council events.

When

Monday, May 22, 2023 (10:30 AM - 12:00 PM)GMT+8

Add to Calendar

Where

Dusit Thani Manila

1223 Epifanio de los Santos Ave, Makati, 12242 Metro Manila, Philippines
Manila, Philippines

Show on map

Event Details

The lack of access to testing in areas outside of Metro Manila remains a significant challenge, with potentially devastating consequences for conditions such as cervical cancer. The prohibitive cost of diagnostics continues to be a significant barrier to access, and consequently, to the diagnosis and treatment of the country's priority diseases. This is despite the country undertaking commendable efforts, such as ongoing efforts to implement its Universal Health Care Act and ratification of the RCEP.


To empower communities and promote informed decision-making, services and programmes in the Philippines will have to be continuously tailored to the needs of affected populations in different settings, including centralised testing with high volume testing labs and treatment in urban and periurban settings and decentralised testing and treatment in rural and remote areas. For the betterment of health for individuals, it is high time that health leaders and regulators in the Philippines work hand in hand with private sectors to accelerate ease of access to better and strengthened diagnostic systems.




In this panel, the various stakeholders will discuss the following:

  • What forms of diagnostics are useful in addressing HIV and cervical cancer, and how soon should patients be diagnosed to get the best treatment?
  • Where are we in bringing access to important diagnostic facilities to Filipinos in regions outside of Metro Manila, and what are we doing to fast-track this?
  • How can diagnostics data be translated into more concrete results to reduce potential health impact? What are the key considerations to upskill healthcare professionals to ensure sufficient manpower and expertise to increase access to screening and care across the country.
  • What are the biggest problems in the current diagnostics landscape in Philippines and what is the biggest hurdles in strengthening this system? How can stakeholders play a role to help change these attitudes and behaviours in Filipinos?
  • What best practices are being adopted in ASEAN countries similar to the Philippines in terms of diagnostics?

Speakers

  • Dr. Janette Loreto-Garin (Representative of the 1st District of Iloilo and former DOH secretary, House of Representatives)

    Dr. Janette Loreto-Garin

    Representative of the 1st District of Iloilo and former DOH secretary, House of Representatives

  • Dr Leila Joudane (Country Representative at UNFPA Philippines)

    Dr Leila Joudane

    Country Representative at UNFPA Philippines

  • Dr Paulo Enrico Belen (President at Philippine Council for Quality Assurance in Clinical Laboratories)

    Dr Paulo Enrico Belen

    President at Philippine Council for Quality Assurance in Clinical Laboratories

  • Marco Valencia Sanchez (GM at Roche Diagnostics Philippines)

    Marco Valencia Sanchez

    GM at Roche Diagnostics Philippines

  • Adrienne Gonzales (Country Manager at Abbott Rapid Diagnostics)

    Adrienne Gonzales

    Country Manager at Abbott Rapid Diagnostics

  • Dr Cecilia Ladines-Llave (MD, PhD, Trustee Director of Cervical Cancer Prevention Network (CECAP) and Philippines Gynecologic Oncologist, Department of OB-Gyne and Cancer Institute, University of the Philippines College of Medicine, Philippine General Hospital)

    Dr Cecilia Ladines-Llave

    MD, PhD, Trustee Director of Cervical Cancer Prevention Network (CECAP) and Philippines Gynecologic Oncologist, Department of OB-Gyne and Cancer Institute, University of the Philippines College of Medicine, Philippine General Hospital

  • Dr Rossana A. Ditangco (MD, Lead of Research Institute for Tropical Medicine and Member of DOH at NASPCP Technical Working Group, Department of Health; NASPCP, National AIDS/STI Prevention and Control Program)

    Dr Rossana A. Ditangco

    MD, Lead of Research Institute for Tropical Medicine and Member of DOH at NASPCP Technical Working Group, Department of Health; NASPCP, National AIDS/STI Prevention and Control Program

  • Dr. Vicente Y. Belizario (President at Philippine Academic Consortium for Public Health)

    Dr. Vicente Y. Belizario

    President at Philippine Academic Consortium for Public Health

  • Kandyce Ong (Associate Director, Healthcare, Southeast Asia of APCO Worldwide)

    Kandyce Ong

    Associate Director, Healthcare, Southeast Asia of APCO Worldwide

Menu